Additionally, Tilray reached a settlement in a securities class action lawsuit against its subsidiary, Aphria, Inc., agreeing to an aggregate payment of approximately US $21 million. The ...

In other recent news, Tilray Brands, Inc. has reached a settlement agreement in a securities class action lawsuit involving its subsidiary, Aphria (NASDAQ:APHA), Inc. The settlement totals CAD $30 ...

In other recent news, Tilray Brands, Inc. has reached a settlement agreement in a securities class action lawsuit involving its subsidiary, Aphria (NASDAQ:APHA), Inc. The settlement totals CAD $30 ...

Tilray Craft's medical cannabis products, including the Tilray Craft, Cannabisblüten THC 25 TAM, are now available across Germany with a physician's prescription at pharmacies. About Tilray ...

Tilray (TLRY) Medical announces the introduction of Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany. Denise Faltischek, Chief ...

NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis ...

Tilray Medical has announced the launch of Tilray Craft, a new brand extension focused on flower-based medical cannabis in Germany. This initiative aims to meet the growing demand for unique ...

NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) — Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering ...